Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 13, 2026, 9:02 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 2497–2520 of 18,278 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Controlled Group Clear all

Conditions: Rosacea
Interventions: CD07805/47 Gel, Vehicle Gel; Drug
Lead sponsor: Galderma R&D; Industry
Eligibility: 18 Years and older
Enrollment: 269 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2011
U.S. locations: 20
States / cities: Hot Springs, Arkansas • San Francisco, California • Newnan, Georgia + 16 more

Conditions: Healthy Volunteers
Interventions: Norditropin, Placebo; Drug
Lead sponsor: National Institute on Aging (NIA); NIH
Eligibility: 25 Years to 50 Years · Male only
Enrollment: 66 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2014
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: General Health, Wellness
Interventions: No Intervention; Other
Lead sponsor: Viome; Industry
Eligibility: Not listed
Enrollment: 20,000 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2028
U.S. locations: 1
States / cities: Bothell, Washington

Conditions: Autism Spectrum Disorder
Interventions: Cognitive Support Technology (CST); Behavioral
Lead sponsor: Kent State University; Other
Eligibility: Not listed
Enrollment: 90 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2024
U.S. locations: 1
States / cities: Kent, Ohio

Conditions: Breast Cancer, Breast Neoplasms
Interventions: Self-Regulation Condition, Enhanced self-Regulation Condition; Behavioral
Lead sponsor: University of Houston; Other
Eligibility: 18 Years and older · Female only
Enrollment: 136 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2016
U.S. locations: 2
States / cities: Los Angeles, California • Houston, Texas

Conditions: Benign Prostatic Hyperplasia
Interventions: tadalafil, placebo; Drug
Lead sponsor: Eli Lilly and Company; Industry
Eligibility: 45 Years and older · Male only
Enrollment: 1,058 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2008
U.S. locations: 1
States / cities: Greenwood, Indiana

Conditions: After Visit Instructions, Patient Education, Teach-Back Communication, Patient Comprehension
Interventions: Standardized After Visit Instructions Only, Standardized After Visit Instructions & Teach Back; Behavioral
Lead sponsor: Rush University Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 75 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2023
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Hypertensive Disorder of Pregnancy, Pre-Eclampsia, Hypertension, Eclampsia, Gestational Hypertension, Cardiovascular Diseases, Toxemia, Pregnancy Complications, Vascular Diseases, Hypertension, Pregnancy Induced, Hypertension;Pre-Eclamptic
Interventions: Low-dose aspirin, Placebo; Drug
Lead sponsor: Malamo Countouris; Other
Eligibility: 18 Years to 55 Years · Female only
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2027
U.S. locations: 1
States / cities: Pittsburgh, Pennsylvania

Conditions: HIV Infections
Interventions: FOYC, Goal for it (GFI), Wonderous Wetlands, Caribbean Informed Parents and Children Together (CImPACT), Bahamian Focus on Older Youth (BFOOY), Health and Family Life Curriculum (HFLE); Behavioral
Lead sponsor: Wayne State University; Other
Eligibility: Not listed
Enrollment: 1,360 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2004 – 2016
U.S. locations: 1
States / cities: Detroit, Michigan

Conditions: Overactive Bladder, Urinary Tract Infection
Interventions: Not listed
Lead sponsor: The Cleveland Clinic; Other
Eligibility: 18 Years and older · Female only
Enrollment: 60 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2007 – 2009
U.S. locations: 1
States / cities: Weston, Florida

Conditions: Cardiometabolic Risk Factors
Interventions: Culinary focused nutrition education, Standard low intensity nutrition education; Behavioral
Lead sponsor: Penn State University; Other
Eligibility: 31 Years to 59 Years
Enrollment: 55 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025
U.S. locations: 1
States / cities: University Park, Pennsylvania

Conditions: Dementia, Stroke, Heart Disease
Interventions: Psychoeducational Support, Information only control group; Behavioral
Lead sponsor: University of Pittsburgh; Other
Eligibility: 21 Years and older
Enrollment: 217 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2013
U.S. locations: 1
States / cities: Pittsburgh, Pennsylvania

Conditions: Severe Acute Respiratory Syndrome, Respiratory Failure, Acute Respiratory Distress Syndrome
Interventions: Alteplase 50 MG [Activase]; Drug
Lead sponsor: Denver Health and Hospital Authority; Other
Eligibility: 18 Years to 75 Years
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2021
U.S. locations: 9
States / cities: La Jolla, California • Aurora, Colorado • Denver, Colorado + 5 more

Conditions: Healthy
Interventions: Breathing training device (Inspiratory Muscle Training), Oura Ring; Device
Lead sponsor: University of California, Los Angeles; Other
Eligibility: 18 Years and older
Enrollment: 150 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2027
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Atopic Dermatitis
Interventions: Zabedosertib (BAY1834845), Placebo to zabedosertib (BAY1834845); Drug
Lead sponsor: Bayer; Industry
Eligibility: 18 Years to 65 Years
Enrollment: 77 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2024
U.S. locations: 4
States / cities: Skokie, Illinois • Boston, Massachusetts • Cincinnati, Ohio + 1 more

Conditions: Congenital Heart Disease, Neurodevelopment, Executive Function, Working Memory Training, Infant Open-heart Surgery
Interventions: Cogmed Working Memory Training; Behavioral
Lead sponsor: Boston Children's Hospital; Other
Eligibility: 13 Years to 16 Years
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2018
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Continuous Positive Airway Pressure, High Altitude Pulmonary Edema
Interventions: CPAP mask system, Nifedipine 30 MG, CPAP mask system without PEEP; Device · Drug
Lead sponsor: CommonSpirit Health; Other
Eligibility: 18 Years and older
Enrollment: 64 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2023
U.S. locations: 1
States / cities: Breckenridge, Colorado

Conditions: Mild Cognitive Disorder, Mild Cognitive Impairment
Interventions: Exelon [rivastigmine] transdermal patch, Placebo transdermal patch; Drug
Lead sponsor: The Cleveland Clinic; Other
Eligibility: 55 Years to 85 Years
Enrollment: 1 participant
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2013
U.S. locations: 1
States / cities: Cleveland, Ohio

Conditions: Dystonia, Tremor
Interventions: repetitive Transcranial Magnetic Stimulation (rTMS), Control group; Device · Other
Lead sponsor: University of Florida; Other
Eligibility: 21 Years to 80 Years
Enrollment: 12 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2022
U.S. locations: 1
States / cities: Gainesville, Florida

Conditions: Prescription Drug Abuse
Interventions: MyHealthyChoices, Health Risk Assessment; Behavioral · Other
Lead sponsor: Johns Hopkins Bloomberg School of Public Health; Other
Eligibility: 18 Years and older
Enrollment: 123 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2017
U.S. locations: 2
States / cities: Baltimore, Maryland • Morgantown, West Virginia

Conditions: Vaccines, Meningococcal Vaccines
Interventions: rLP2086 and Gardasil, rLP2086, Gardasil; Biological
Lead sponsor: Pfizer; Industry
Eligibility: 11 Years to 17 Years
Enrollment: 2,499 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2011 – 2013
U.S. locations: 87
States / cities: Daphne, Alabama • Chandler, Arizona • Jonesboro, Arkansas + 57 more

Conditions: Coronavirus
Interventions: Messaging; Behavioral
Lead sponsor: National Bureau of Economic Research, Inc.; Other
Eligibility: 18 Years and older
Enrollment: 14,267 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020
U.S. locations: 1
States / cities: Cambridge, Massachusetts

Conditions: Gestational Diabetes Mellitus in Pregnancy, Type 2 Diabetes Mellitus
Interventions: Fresh Funds for Mom's, Standard Medical care, Medically Tailored Frozen Meals; Behavioral
Lead sponsor: Alison Gustafson; Other
Eligibility: 18 Years to 55 Years · Female only
Enrollment: 22 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2024
U.S. locations: 2
States / cities: Lexington, Kentucky • Louisville, Kentucky

Conditions: Malnutrition
Interventions: Quality Improvement Program; Other
Lead sponsor: Abbott Nutrition; Industry
Eligibility: 18 Years and older
Enrollment: 1,546 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2018
U.S. locations: 2
States / cities: Des Plaines, Illinois • Oak Lawn, Illinois

Search by objective public record fields.

Efficacy and Safety Study of CD07805/47 Topical Gel in Subjects With Facial Erythema Associated With Rosacea

Growth Hormone Administration and the Human Immune System

Collection and Analyses of Physiological, Physical, and Molecular Data From a Diverse Population

Cognitive Support Technology for Postsecondary Students With Autism Spectrum Disorder

Health Benefits of Expressive Writing Among Chinese Breast Cancer Survivors

Study of Tadalafil Once-a Day for 12 Weeks in Men With Signs and Symptoms of Benign Prostatic Hyperplasia

Impact of After Visit Instructions on Patient Comprehension

Treatment With Aspirin After Preeclampsia: TAP Trial

HIV Risk Reduction in Youth in the Bahamas

Urinary Cytokines in Patients With Overactive Bladder (OAB)

SPICE UP MyPlate - Strategy for Promoting Intake of Delicious Healthful Dietary Patterns Based on MyPlate: A Pilot Study

Facilitating Caregiver Adaptation to Patient Institutionalization

Fibrinolytic Therapy to Treat ARDS in the Setting of COVID-19 Infection

BreatheWell: Train Your Breathing, Relax Your Body, Open Your Mind

A Study to Learn How Well the Study Treatment Zabedosertib (BAY1834845) Works and How Safe it is Compared to Placebo in Adult Participants With Moderate-to-severe Atopic Dermatitis

Improving Neurodevelopment in Adolescents With Congenital Heart Disease

Evaluating the Utility of Continuous Positive Airway Pressure in the Treatment of High Altitude Pulmonary Edema

Study of Exelon Transdermal Patch in Amnestic Mild Cognitive Impairment Patients

Repetitive Transcranial Magnetic Stimulation (rTMS) for Dystonia and Tremor

Using m-Health Tools to Reduce the Misuse of Opioid Pain Relievers

A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to Gardasil and Bivalent rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 11 and 17

COVID-19 Health Messaging to Underserved Communities

Fresh Carts for Mom's to Improve Food Security and Glucose Management

Impact of a Nutrition Quality Improvement Program on Outcomes of Malnourished Patients